Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BG Medicine Inc BGMD

Metals & Mining Technology Industrial Metals & Minerals Scientific & Technical Instruments
BG Medicine, Inc. (BG Medicine) is a commercial-stage diagnostics company. The Company is engaged in commercializing diagnostic products that may be used to help guide the care and management of patients suffering from heart failure and related disorders. The Company's BGM Galectin-3 Test is an in vitro diagnostic device that employs a manual micro-titer platform to measure galectin-3 levels in... see more

Recent & Breaking News (GREY:BGMD)

Critical Diagnostics Launches Rapid Test for Managing Heart Failure Patients

Business Wire March 10, 2015

BG Medicine Announces Receipt of Favorable NASDAQ Listing Determination

GlobeNewswire February 2, 2015

BG Medicine, Inc. Welcomes Presentation of Clinical Data on Galectin-3 Testing at the American Heart Association 2014 Scientific Sessions Conference

GlobeNewswire November 20, 2014

BG Medicine Reports Third Quarter 2014 Financial Results

GlobeNewswire November 13, 2014

BG Medicine Announces Q3 2014 Financial Results Release Date and Conference Call Information

GlobeNewswire November 7, 2014

BG Medicine Reports Second Quarter 2014 Financial Results

GlobeNewswire August 14, 2014

BG Medicine Announces Q2 2014 Financial Results Release Date and Conference Call Information

GlobeNewswire August 7, 2014

BG Medicine Reports First Quarter 2014 Financial Results

GlobeNewswire May 14, 2014

BG Medicine Announces Q1 2014 Financial Results Release Date and Conference Call Information

GlobeNewswire May 7, 2014

BG Medicine (BGMD) Stock Plunges as Market Corrects for Pricing of Public Offering

Equities.com April 3, 2014

BG Medicine, Inc. Prices $10.0 Million Public Offering of Common Stock

GlobeNewswire April 3, 2014

BG Medicine, Inc. Announces Proposed Public Offering of Common Stock

GlobeNewswire April 2, 2014

Publication Reports Clinical Utility of BGM Galectin-3(R) Test for Prediction of Near-Term Rehospitalization in Patients With Heart Failure

GlobeNewswire March 25, 2014

Wall Street Rallies as Domestic and Global Economic Data Favors Buying

Equities.com March 25, 2014

BG Medicine (BGMD) Climbs to New 52-Week High on Publication of Study Results

Equities.com March 25, 2014

Lawsuits, Clinical Studies, Financial Results, and Stock Movements - Analyst Notes on Idenix, BG Medicine, Progenics, Omeros, and Opexa

PR Newswire March 21, 2014

Wall Street Shrugs Off Yellen's Taper Talk as Stocks Rebound Across the Board

Equities.com March 20, 2014

BG Medicine (BGMD) Spikes on Strong 2013 Earnings

Equities.com March 20, 2014

BG Medicine Announces Issuance of Patent Covering Galectin-3 Testing for Cardiac Resynchronization Therapy

GlobeNewswire March 20, 2014

BG Medicine Reports 2013 Fourth Quarter and Year End Financial Results

GlobeNewswire March 20, 2014